When evaluating a new disinfectant, theinfection preventionist's primary concern must be the safety and effectiveness of the product. This includes ensuring the product is EPA-registered, effective against targeted pathogens, safe for both the environment and users, and compliant with regulatory guidelines.
From theAPIC/JCR Workbook, key considerations include:
“Organizations should evaluate each product to ensure that it can be used safely and include a review of dilutions, storage, shelf life, PPE needed, and disposal and ventilation requirements to ensure that OSHA, EPA, or local requirements are met”.
"Safety and efficacy are critical factors in evaluating new products, with particular emphasis on infection prevention and user safety".
The other options, while relevant, are not the most critical factors in determining product adoption from an infection control standpoint.
[References:, APIC/JCR Workbook, 4th Edition, Chapter 8 – Disinfection and Sterilization, CBIC Study Guide, 6th Edition, Product Evaluation Section, , ]
